Th1 immune response toPlasmodium falciparumrecombinant thrombospondin-related adhesive protein (TRAP) antigen is enhanced by TLR3-specific adjuvant, poly(I:C) in BALB/c mice-Reference-Cited by-同舟云学术

Th1 immune response toPlasmodium falciparumrecombinant thrombospondin-related adhesive protein (TRAP) antigen is enhanced by TLR3-specific adjuvant, poly(I:C) in BALB/c mice

Published:2018-06-27 Issue:7 Volume:40 Page:e12538
ISSN:0141-9838
Container-title:Parasite Immunology
language:en
Short-container-title:Parasite Immunol

Author:

Mehrizi A. A.¹^ORCID,Ameri Torzani M.¹²,Zakeri S.¹^ORCID,Jafary Zadeh A.¹,Babaeekhou L.²

Affiliation:

1. Malaria and Vector Research Group (MVRG); Biotechnology Research Center (BRC); Pasteur Institute of Iran; Tehran Iran

2. Department of Biology; Islamshahr Branch; Islamic Azad University; Islamshahr Iran

Funder

Deputy of Research and Technology

Ministry of Health and Medical Education of Iran

Pasteur Institute of Iran

Publisher

Wiley

Subject

Immunology,Parasitology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pim.12538/fullpdf

Reference94 articles.

1. WHO malaria report 2016 www.who.int/malaria/publications/world-malaria-report-2016/report/en/

2. Spread of artemisinin resistance in Plasmodium falciparum malaria;Ashley;N Engl J Med,2014

3. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children;Agnandji;N Engl J Med,2011

4. Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites;RTS,S Clinical Trials Partnership;PLoS Med,2014

5. Design of a phase III multicenter trial to evaluate the efficacy of the RTS, S/AS01 malaria vaccine in children across diverse transmission settings in Africa;Leach;Malar J,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malaria transmission blocking activity of Anopheles stephensi alanyl aminopeptidase N antigen formulated with MPL, CpG, and QS21 adjuvants;PLOS ONE;2024-07-05

2. Pathogenesis of Plasmodium falciparum;Drug Targets for Plasmodium Falciparum: Historic to Future Perspectives;2024

3. CRISPR/Cas advancements for genome editing, diagnosis, therapeutics, and vaccine development for Plasmodium parasites, and genetic engineering of Anopheles mosquito vector;Infection, Genetics and Evolution;2023-04

4. Host-parasite interactions during Plasmodium infection: Implications for immunotherapies;Frontiers in Immunology;2023-01-04

5. Immune System Modulation by the Adjuvants Poly (I:C) and Montanide ISA 720;Frontiers in Immunology;2022-06-29